BSX - Company ID 0000885725
BOSTON SCIENTIFIC CORP trades as BSX and has a market capitalization of $66.87 B, making it the #256 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $20.07B, up 19.9% from the prior year. This page tracks BOSTON SCIENTIFIC CORP through 1,009 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years BOSTON SCIENTIFIC CORP's revenue grew from $9.08B to $20.07B, a compound annual growth rate of 9.2%.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| SD | - | 2026-05-21 |
| Major company event | 8-K | 2026-05-18 |
| Major company event | 8-K | 2026-05-18 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
Find products, medical specialty information, and education opportunities.
Find products, medical specialty information, and education opportunities.
Find products, medical specialty information, and education opportunities.
Find products, medical specialty information, and education opportunities.
The largest companies sharing BOSTON SCIENTIFIC CORP's SEC industry classification (surgical & medical instruments & apparatus).
BOSTON SCIENTIFIC CORP (BSX) has a market capitalization of $66.87 B as of 2026-07-09, ranking #256 among US-listed companies.
BOSTON SCIENTIFIC CORP reported revenue of $20.07B for fiscal year 2025, an increase of 19.9% year over year.